Browsing Tag
Crewe Capital
1 post
Clene Nanomedicine raises $42.5m for developing nanocatalysts for neurodegenerative diseases
Clene Nanomedicine, which is engaged in developing nanocatalysts for the treatment of bioenergetic failure associated with neurodegenerative diseases,…